Futura Medical due $5m milestone payment from Haleon
Futura Medical
33.45p
15:54 07/10/24
Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
FTSE 100
8,298.85
16:10 07/10/24
FTSE 350
4,576.26
16:10 07/10/24
FTSE AIM All-Share
738.38
16:10 07/10/24
FTSE All-Share
4,533.10
16:10 07/10/24
Haleon
376.00p
16:10 07/10/24
Pharmaceuticals & Biotechnology
22,219.89
16:10 07/10/24
The AIM-traded firm said the milestone followed the successful distribution of online pre-orders and the availability of Eroxon in US retail stores.
It said the payment was expected to be received shortly.
Eroxon, Futura’s flagship product, is a clinically-proven sexual health product.
The milestone payment was another key step in its ongoing strategy to commercialise its products globally, with the US launch being a major milestone in the product’s growth.
At 1356 BST, shares in Futura Medical were up 2.77% at 33.45p.
Reporting by Josh White for Sharecast.com.